However, in another trial based on epacadostat plus a multipeptide melanoma vaccine, besides normalized serum kynurenine/tryptophan ratios in most patients, data indicated an enhancement of CD8+ T cell infiltration in tumor milieu in patients with melanoma submitted to the combination therapy (clinical trial information: NCT01961115) (26). The gene discussed is CD8A; the disease is neoplasm.